Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 73 articles: HTML format Text format

Single Articles

January 2012
1. SMITH AL , Iwanaga R, Drasin DJ, Micalizzi DS, et al
   The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
   Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. URSINI-SIEGEL J , Hardy WR, Zheng Y, Ling C, et al
   The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.
   Oncogene. 2012 Jan 30. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MARUANI DM , Spiegel TN, Harris EN, Shachter AS, et al
   Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
   Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BELGUISE K , Milord S, Galtier F, Moquet-Torcy G, et al
   The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.
   Oncogene. 2012 Jan 30. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SAMANTA S , Sharma VM, Khan A, Mercurio AM, et al
   Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. THALER S , Schmidt M, Schad A, Sleeman JP, et al
   RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. LUKER KE , Lewin SA, Mihalko LA, Schmidt BT, et al
   Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CASTORIA G , Giovannelli P, Lombardi M, De Rosa C, et al
   Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. NAIRISMAGI ML , Vislovukh A, Meng Q, Kratassiouk G, et al
   Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. NIEMELA M , Kauko O, Sihto H, Mpindi JP, et al
    CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CUTRUPI S , Reineri S, Panetto A, Grosso E, et al
    Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. WANG J , Ray PS, Sim MS, Zhou XZ, et al
    FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-kappaB signaling.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WEE EJ , Peters K, Nair SS, Hulf T, et al
    Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in
    Oncogene. 2012 Jan 9. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PARIS O , Ferraro L, Grober OM, Ravo M, et al
    Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
    Oncogene. 2012 Jan 9. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
15. ANASTAS JN , Biechele TL, Robitaille M, Muster J, et al
    A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
    Oncogene. 2011 Dec 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KEKLIKOGLOU I , Koerner C, Schmidt C, Zhang JD, et al
    MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways.
    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. KHANAL P , Yun HJ, Lim SC, Ahn SG, et al
    Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. PRADEEP CR , Zeisel A, Kostler WJ, Lauriola M, et al
    Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BRENNAN DJ , O'Connor DP, Laursen H, McGee SF, et al
    The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERalpha, and is an independent prognostic factor in node-negative breast cancer.
    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
20. BONNOMET A , Syne L, Brysse A, Feyereisen E, et al
    A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.
    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SHRESTHA Y , Schafer EJ, Boehm JS, Thomas SR, et al
    PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling.
    Oncogene. 2011 Nov 21. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. PARONI G , Fratelli M, Gardini G, Bassano C, et al
    Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Oncogene. 2011 Nov 7. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HARRIS LG , Pannell LK, Singh S, Samant RS, et al
    Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.
    Oncogene. 2011 Nov 7. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. VESUNA F , Lisok A, Kimble B, Domek J, et al
    Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-alpha
    Oncogene. 2011 Nov 7. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
25. LIAO YC , Ruan JW, Lua I, Li MH, et al
    Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
    Oncogene. 2011 Oct 17. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WANG L , Wang J
    MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.
    Oncogene. 2011 Oct 3. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
27. BUIJS JT , van der Horst G, van den Hoogen C, Cheung H, et al
    The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. FANALE D , Amodeo V, Corsini LR, Rizzo S, et al
    Breast cancer genome-wide association studies: there is strength in numbers.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CHERIYATH V , Kuhns MA, Jacobs BS, Evangelista P, et al
    G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. DURAN-PRADO M , Gahete MD, Hergueta-Redondo M, Martinez-Fuentes AJ, et al
    The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.
    Oncogene. 2011 Sep 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. STIEHL DP , Bordoli MR, Abreu-Rodriguez I, Wollenick K, et al
    Non-canonical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
    Oncogene. 2011 Sep 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. NOETZEL E , Rose M, Bornemann J, Gajewski M, et al
    Nuclear transport receptor karyopherin-alpha2 promotes malignant breast cancer phenotypes in vitro.
    Oncogene. 2011 Sep 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MAMO A , Cavallone L, Tuzmen S, Chabot C, et al
    An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer.
    Oncogene. 2011 Sep 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CHU IM , Michalowski AM, Hoenerhoff M, Szauter KM, et al
    GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
    Oncogene. 2011 Sep 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
35. PARANJAPE AN , Mandal T, Mukherjee G, Kumar MV, et al
    Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Oncogene. 2011 Aug 29. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KARADEDOU CT , Gomes AR, Chen J, Petkovic M, et al
    FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. STOSSI F , Madak-Erdogan Z, Katzenellenbogen BS
    Macrophage-elicited loss of estrogen receptor-alpha in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus.
    Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ZHANG H , Wong CC, Wei H, Gilkes DM, et al
    HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.
    Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. MIYAKE T , Parsons SJ
    Functional interactions between Choline kinase alpha, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.
    Oncogene. 2011 Aug 8. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. LEIS O , Eguiara A, Lopez-Arribillaga E, Alberdi MJ, et al
    Sox2 expression in breast tumours and activation in breast cancer stem cells.
    Oncogene. 2011 Aug 8. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
41. LAKSHMANAN I , Ponnusamy MP, Das S, Chakraborty S, et al
    MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.
    Oncogene. 2011 Jul 25. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GUEDJ M , Marisa L, de Reynies A, Orsetti B, et al
    A refined molecular taxonomy of breast cancer.
    Oncogene. 2011 Jul 25. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. REGAN JL , Kendrick H, Magnay FA, Vafaizadeh V, et al
    c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KIM K , Chadalapaka G, Lee SO, Yamada D, et al
    Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MCINNES N , Sadlon TJ, Brown CY, Pederson S, et al
    FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.
    Oncogene. 2011 Jul 11. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. TERRINONI A , Pagani IS, Zucchi I, Chiaravalli AM, et al
    OTX1 expression in breast cancer is regulated by p53.
    Oncogene. 2011;30:3104.
    PubMed     Text format     Related articles   
    
    
    
    
47. SMIRNOVA T , Zhou ZN, Flinn RJ, Wyckoff J, et al
    Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
    Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
48. HUANG B , Qu Z, Ong CW, Tsang YH, et al
    RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha
    Oncogene. 2011 Jun 27. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SHENOY SK , Han S, Zhao YL, Hara MR, et al
    beta-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression.
    Oncogene. 2011 Jun 20. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. WU J , Liu S, Liu G, Dombkowski A, et al
    Identification and functional analysis of 9p24 amplified genes in human breast cancer.
    Oncogene. 2011 Jun 13. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KONDRATYEV M , Kreso A, Hallett RM, Girgis-Gabardo A, et al
    Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
    Oncogene. 2011 Jun 13. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. BERGAMASCHI A , Katzenellenbogen BS
    Tamoxifen downregulation of miR-451 increases 14-3-3zeta and promotes breast cancer cell survival and endocrine resistance.
    Oncogene. 2011 Jun 13. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. CAO X , Geradts J, Dewhirst MW, Lo HW, et al
    Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.
    Oncogene. 2011 Jun 13. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
54. FANG X , Cai Y, Liu J, Wang Z, et al
    Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BU W , Chen J, Morrison GD, Huang S, et al
    Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. YANG L , Wu X, Wang Y, Zhang K, et al
    FZD7 has a critical role in cell proliferation in triple negative breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
57. XING F , Okuda H, Watabe M, Kobayashi A, et al
    Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. FUJII S , Tokita K, Wada N, Ito K, et al
    MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. GIORDANO C , Catalano S, Panza S, Vizza D, et al
    Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. TANIZAKI J , Okamoto I, Fumita S, Okamoto W, et al
    Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ASTRO V , Asperti C, Cangi MG, Doglioni C, et al
    Liprin-alpha1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation.
    Oncogene. 2011;30:1850.
    PubMed     Text format     Related articles   
    
    
    
    
62. FOURNIER G , Cabaud O, Josselin E, Chaix A, et al
    Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. TERRINONI A , Pagani IS, Zucchi I, Chiaravalli AM, et al
    OTX1 expression in breast cancer is regulated by p53.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. BOULAY PL , Schlienger S, Lewis-Saravalli S, Vitale N, et al
    ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
65. BIST P , Leow SC, Phua QH, Shu S, et al
    Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ROBERTS CG , Millar EK, O'Toole SA, McNeil CM, et al
    Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
67. BUACHE E , Etique N, Alpy F, Stoll I, et al
    Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. WEIGELT B , Warne PH, Downward J
    PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. PRIVETTE VINNEDGE LM , McClaine R, Wagh PK, Wikenheiser-Brokamp KA, et al
    The human DEK oncogene stimulates beta-catenin signaling, invasion and mammosphere formation in breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
70. SERRA V , Scaltriti M, Prudkin L, Eichhorn PJ, et al
    PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. HWANG-VERSLUES WW , Chang PH, Wei PC, Yang CY, et al
    miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. BOOY EP , Henson ES, Gibson SB
    Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. YU F , Li J, Chen H, Fu J, et al
    Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: